T. Rowe Price Associates’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25.7M | Sell |
|
|||||
|
2025
Q1 | $34.6M | Sell |
|
|||||
|
2024
Q4 | $172M | Sell |
|
|||||
|
2024
Q3 | $379M | Sell |
|
|||||
|
2024
Q2 | $558M | Sell |
|
|||||
|
2024
Q1 | $804M | Sell |
|
|||||
|
2023
Q4 | $820M | Sell |
|
|||||
|
2023
Q3 | $941M | Sell |
|
|||||
|
2023
Q2 | $1.09B | Sell |
|
|||||
|
2023
Q1 | $985M | Buy |
|
|||||
|
2022
Q4 | $542M | Sell |
|
|||||
|
2022
Q3 | $952M | Sell |
|
|||||
|
2022
Q2 | $1.89B | Sell |
|
|||||
|
2022
Q1 | $2.62B | Buy |
|
|||||
|
2021
Q4 | $2.93B | Buy |
|
|||||
|
2021
Q3 | $2.16B | Sell |
|
|||||
|
2021
Q2 | $1.92B | Buy |
|
|||||
|
2021
Q1 | $1.41B | Buy |
|
|||||
|
2020
Q4 | $1.31B | Buy |
|
|||||
|
2020
Q3 | $1.22B | Sell |
|
|||||
|
2020
Q2 | $1.2B | Sell |
|
|||||
|
2020
Q1 | $810M | Sell |
|
|||||
|
2019
Q4 | $1.03B | Sell |
|
|||||
|
2019
Q3 | $1.24B | Sell |
|
|||||
|
2019
Q2 | $1.11B | Buy |
|
|||||
|
2019
Q1 | $966M | Sell |
|
|||||
|
2018
Q4 | $882M | Buy |
|
|||||
|
2018
Q3 | $1.1B | Sell |
|
|||||
|
2018
Q2 | $957M | Sell |
|
|||||
|
2018
Q1 | $857M | Buy |
|
|||||
|
2017
Q4 | $919M | Sell |
|
|||||
|
2017
Q3 | $904M | Buy |
|
|||||
|
2017
Q2 | $878M | Sell |
|
|||||
|
2017
Q1 | $758M | Sell |
|
|||||
|
2016
Q4 | $832M | Buy |
|
|||||
|
2016
Q3 | $698M | Buy |
|
|||||
|
2016
Q2 | $680M | Sell |
|
|||||
|
2016
Q1 | $622M | Buy |
|
|||||
|
2015
Q4 | $517M | Buy |
|
|||||
|
2015
Q3 | $429M | Buy |
|
|||||
|
2015
Q2 | $378M | Buy |
|
|||||
|
2015
Q1 | $309M | Buy |
|
|||||
|
2014
Q4 | $103M | Sell |
|
|||||
|
2014
Q3 | $88.2M | Sell |
|
|||||
|
2014
Q2 | $84.1M | Buy |
|
|||||
|
2014
Q1 | $87.3M | Sell |
|
|||||
|
2013
Q4 | $97.6M | Buy |
|
|||||
|
2013
Q3 | $80.2M | Buy |
|
|||||
|
2013
Q2 | $63.3M | Buy |
|